Multitargeted antiangiogenic tyrosine kinase inhibitors combined to chemotherapy in metastatic breast cancer: a systematic review and meta-analysis.
Purpose: We undertook a meta-analysis of randomized trials to evaluate the efficacy of multitargeted antiangiogenic tyrosine kinase inhibitors (MATKIs) in addition to chemotherapy in metastatic breast cancer. Methods: PubMed, Web of Knowledge databases and the ASCO meeting abstracts were searched fo...
| Publicado en: | European Journal of Clinical Pharmacology Vol. 70; no. 5; pp. 531 - 539 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
Springer Nature
May2014
|
| Acceso en línea: | Ver este registro en EBSCOhost |